Back to Search Start Over

Detection and Initial Response to a Type 2 Vaccine-Derived Poliovirus — Sichuan Province, China, 2019

Authors :
Aiqiang Xu
Hong Yang
Jiushun Zhou
Lixin Hao
Yong Zhang
Ning Wen
Wenbo Xu
Yong Chen
Xiaoping Zhu
Zundong Yin
Chao Ma
Yu Liu
Xianxiang Ding
Qian-Li Ma
Kun Deng
Huaqing Wang
Chunxiang Fan
Xiaozhen Ma
Ge Shao
Zhijie An
Qi Qi
Lei Cao
Lance Rodewald
Lei Nan
Cheng Wang
Dongmei Yan
Xianping Wu
Zijian Feng
Shuangli Zhu
Source :
China CDC Weekly. 2:172-175
Publication Year :
2020
Publisher :
Chinese Center for Disease Control and Prevention, 2020.

Abstract

What is already known about this topic? After the type 2 strain of the live, attenuated poliovirus vaccine was withdrawn globally in 2016, any identification of a type 2 poliovirus is a Public Health Emergency of International Concern. A vaccine-derived type 2 poliovirus (VDPV2) was identified in Sichuan, prompting an urgent, comprehensive investigation and response. What is added by this report? Type 2 monovalent, live, attenuated oral poliovirus vaccine (mOPV2) is being used to respond to the numerous VDPV2 outbreaks seen around the world. In contrast, the response in Sichuan used Sabin strain inactivated poliovirus (sIPV) to stop circulation of the VDPV2. In the 6 months following the vaccination response, there have been no VDPV2s detected in Sichuan, despite extensive search. What are the implications for public health practices? Further search for the VDPV2 must continue in order to determine whether transmission has been stopped. The ongoing investigation and response to the Sichuan VDPV2 is providing evidence to the Global Polio Eradication Initiative on managing VDPV2 outbreaks.

Details

ISSN :
20967071
Volume :
2
Database :
OpenAIRE
Journal :
China CDC Weekly
Accession number :
edsair.doi...........a77b51b1f59f00412dcd16a31a76e0a0